Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 622 of 5804
-
Early preeclampsia test could save thousands of newborns and moms
Prevention Recruiting nowThe purpose of this study is to determine whether first-trimester screening for preeclampsia based on the FMF algorithm (a combination of maternal clinical, sonographic and biochemical parameters), improves maternal or perinatal health.
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
New hope for COPD patients: drug aims to cut severe Flare-Ups
Disease control CompletedSubjects who completed either OBERON or TITANIA will be offered the opportunity to consent for this Multicentre, Double-blind, Randomised, Placebo controlled, Parallel Group, Phase 3, extension study to evaluate the safety and efficacy of Tozorakimab in adult participants with sy…
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug could slow liver damage in rare genetic disease
Disease control Recruiting nowThe main aim of this study is to learn if fazirsiran reduces liver scarring (fibrosis) compared to placebo. Other aims are to learn if fazirsiran slows down the disease worsening in the liver, to get information on how fazirsiran affects the body (called pharmacodynamics), to lea…
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
On-the-Spot hep c care at methadone clinics boosts cure rates
⭐️ CURE ⭐️ CompletedThe goal of this pragmatic, quasi-experimental cluster trial is to evaluate whether simplified, onsite hepatitis C virus (HCV) treatment integrated into opioid agonist maintenance therapy (OAMT) clinics improves cure rates compared with referral-based care in Ukraine . The study …
Phase: NA • Sponsor: Ukrainian Institute on Public Health Policy • Aim: ⭐️ CURE ⭐️
Last updated Jun 27, 2026 12:29 UTC
-
New weekly injection shows promise for boosting growth in kids with dwarfism
Disease control CompletedThe purpose of this clinical trial was to evaluate efficacy and safety of once weekly subcutaneous (SC) doses of 100 µg TransCon CNP/kg compared to placebo on Annualized Growth Velocity after a 52-week randomized treatment period in children aged 2 to 11 years with genetically co…
Phase: PHASE2, PHASE3 • Sponsor: Ascendis Pharma Growth Disorders A/S • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Can a pill speed up monkeypox recovery? major trial underway
Disease control OngoingThe overall purpose of this study is to evaluate whether tecovirimat is an efficient and safe antiviral in the treatment of monkeypox in adults and adolescents (14 years old and older). The primary objective is to evaluate the clinical efficacy, as assessed by time to all visibl…
Phase: PHASE3 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug combo shows promise in shrinking Hard-to-Treat breast tumors
Disease control CompletedThe purpose of this clinical trial is to evaluate the efficacy and safety of Fluzoparib combined with docetaxel in sequential paclitaxel combined with cyclophosphamide for HRD-positive, HR+/HER2- early breast cancer. The main question it aims to answer is: Does the proportion of…
Phase: PHASE2 • Sponsor: Xijing Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Could a targeted drug boost chemo for osteosarcoma?
Disease control Recruiting nowThis phase II/III trial tests the safety, side effects, and best dose of the drug cabozantinib in combination with standard chemotherapy, and to compare the effect of adding cabozantinib to standard chemotherapy alone in treating patients with newly diagnosed osteosarcoma. Caboza…
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Smart drugs take on rare salivary gland cancer in new trial
Disease control Recruiting nowThis phase II trial compares the effect of usual treatment of docetaxel chemotherapy plus trastuzumab, to ado-emtansine (T-DM1) in patients with HER2-postive salivary gland cancer that has come back (recurrent), that has spread from where it first started (primary site) to other …
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Could an extra shingles shot protect transplant patients?
⭐️ VACCINE ⭐️ Recruiting nowThe goal of this clinical trial is to learn how well the shingles vaccine (Shingrix) works and how safe it is in adults with kidney failure who are waiting for a kidney transplant, including those who later receive a transplant. The study also aims to find out whether giving an e…
Phase: PHASE3 • Sponsor: University of Colorado, Denver • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:05 UTC
-
Could a Two-Session online therapy ease earthquake trauma?
Symptom relief CompletedThis pilot randomized controlled trial evaluated the preliminary effects of the online EMDR Flash Group Protocol among adults affected by the 2023 Kahramanmaraş earthquakes in Türkiye. Participants were randomly assigned to either the EMDR Flash Group Protocol or a waitlist contr…
Phase: NA • Sponsor: Istanbul Galata University • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
New lupus drug shows promise in major trial
Disease control OngoingThe trial will evaluate efficacy, safety and tolerability of two regimens of ianalumab compared to placebo, given as monthly or quarterly subcutaneous (s.c.) injection on top of standard-of-care (SoC) treatment in participants with active systemic lupus erythematosus (SLE).
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Could a melanoma drug combo tame rare BRAF cancers?
Disease control Recruiting nowThis clinical trial is looking at a combination of drugs called vemurafenib and cobimetinib. Vemurafenib is approved as standard of care for adult patients with unresectable or metastatic melanoma. Cobimetinib is approved as standard of care in combination with vemurafenib for th…
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New drug combo shows promise against hodgkin lymphoma
Disease control CompletedThis study will be held in the clinical oncology department, Helwan University, and Police Hospital, aiming to compare the efficacy and safety of anti-CD30 (BV) + Doxorubicin, Vinblastine, and Dacarbazine (AVD) versus the standard of care Doxorubicin, Bleomycin, Vinblastine, and …
Phase: NA • Sponsor: Helwan University • Aim: Disease control
Last updated Jun 26, 2026 17:09 UTC
-
New trial combines drugs with surgery or radiation to fight advanced prostate cancer
Disease control Recruiting nowItalian multicenter study, will enroll \~566 pts with oligometastatic hormone sensitive prostate cancer who are candidates to receive treatment with apalutamide. After 6 months from the start of treatment, patients will be randomized to receive local treatment based on the inves…
Phase: NA • Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Disease control
Last updated Jun 26, 2026 13:15 UTC
-
HIV heart risk targeted: new drug trial aims to quiet arterial inflammation
Disease control Recruiting nowThis is a randomized placebo-controlled study in treated and suppressed HIV-infected individuals aged ≥40 years with either known CVD or 1 CVD risk factor to study the effect of Bempedoic acid (BA) on safety, arterial inflammation as assessed by FDG-PET/CT, lipids, inflammation, …
Phase: PHASE2 • Sponsor: Priscilla Hsue, MD • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a weekly shot slash heart attack risk? major trial underway
Disease control OngoingThis study will look at the effects of CagriSema on cardiovascular events (for example heart attack and stroke) in people living with cardiovascular disease. Participants will either get CagriSema or a dummy medicine (also called "placebo") which has no effect on the body. Which …
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Bladder cancer patients may skip surgery with new drug combo
Disease control OngoingIntravesical immunotherapy or chemotherapy for non-muscle invasive bladder cancer (NMIBC) is a well-established treatment for preventing or delaying tumor recurrence after tumor resection. For high-risk non-muscle invasive bladder cancer, immunotherapy in the form of intravesical…
Phase: PHASE2 • Sponsor: University of Arizona • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
AI reads scans to spot esophageal cancer and predicts best treatment path
Diagnosis OngoingThis study intends to construct two multimodal deep learning models: one for the diagnosis of esophageal cancer and the prediction of invasive depth to assess suitability for endoscopic resection; the other model, based on this, classifies endoscopic non-resectable patients into …
Sponsor: Shanghai Zhongshan Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
Arterial chemo combo shows promise in stomach cancer trial
Disease control Recruiting nowSOX regimen, consisting of oral S-1 and intravenous oxaliplatin, is the preferred regimen for perioperative chemotherapy for gastric cancer. The goal of this clinical trial is to compare the efficacy and safety between S-1 combined with oxaliplatin by arterial infusion, as neoadj…
Phase: PHASE3 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC